A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+/HER2- Breast Cancer After Failure of Prior Endocrine Therapy(PANKU-Breast03)
Clinical trial NCT07648914 · RECRUITING
Trial details
- NCT number
- NCT07648914
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-06
- Primary completion
- 2028-12-01
- Enrollment
- 446
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.